---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-001606"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:01:46.165651+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences reports FY2023 net loss of $4.1M; cash at $9.0M

## Summary
- Net loss of $4.1M for year ended Dec 31, 2023; R&D expenses down 26.7% to $3.5M.
- Royalty payments from Takeda sublicense rose 48.8% to $2.5M in 2023.
- Cash and cash equivalents of $9.0M at year-end to fund operations.
- Advancing DNase-based oncology platform targeting pancreatic carcinoma toward Phase 1 trial.
- Entered research funding and material transfer agreement with University of Virginia.

## SEC filing metadata
- accession: 0001683168-24-001606
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316824001606/0001683168-24-001606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316824001606/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-001606
- JSON: https://secwatch.observer/filing/0001683168-24-001606.json
- Plain text: https://secwatch.observer/filing/0001683168-24-001606.txt

## Key facts
- Earnings Releases
  Xenetic Biosciences, Inc. reported the year ended December 31, 2023 results: net income approximately $4.1 million.
  - Period: the year ended December 31, 2023
  - Net income: approximately $4.1 million
  - Result: reported results
  source text: Net loss for the year ended December 31, 2023 was approximately $4.1 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316824001606/0001683168-24-001606-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.